vs
American Assets Trust, Inc.（AAT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
American Assets Trust, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.6倍（$110.6M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 6.1%，领先377.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 1.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -0.1%）
该公司是一家大型英国投资信托，在伦敦证券交易所上市，同时是富时250指数的成分股，现任董事长为获颁CBE勋章的伊恩·弗格森。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AAT vs RIGL — 直观对比
营收规模更大
AAT
是对方的1.6倍
$69.8M
营收增速更快
RIGL
高出19.4%
1.8%
净利率更高
RIGL
高出377.9%
6.1%
两年增速更快
RIGL
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $110.6M | $69.8M |
| 净利润 | $6.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 23.4% | 33.2% |
| 净利率 | 6.1% | 384.0% |
| 营收同比 | 1.8% | 21.2% |
| 净利润同比 | -16.3% | 1769.2% |
| 每股收益（稀释后） | $0.08 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AATRIGL
| Q1 26 | $110.6M | — | ||
| Q4 25 | $110.1M | $69.8M | ||
| Q3 25 | $109.6M | $69.5M | ||
| Q2 25 | $107.9M | $101.7M | ||
| Q1 25 | $108.6M | $53.3M | ||
| Q4 24 | $113.5M | $57.6M | ||
| Q3 24 | $122.8M | $55.3M | ||
| Q2 24 | $110.9M | $36.8M |
净利润AATRIGL
| Q1 26 | $6.7M | — | ||
| Q4 25 | — | $268.1M | ||
| Q3 25 | $4.5M | $27.9M | ||
| Q2 25 | $5.5M | $59.6M | ||
| Q1 25 | $42.5M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $16.7M | $12.4M | ||
| Q2 24 | $11.9M | $-1.0M |
毛利率AATRIGL
| Q1 26 | — | — | ||
| Q4 25 | 59.4% | 91.5% | ||
| Q3 25 | 60.5% | 93.2% | ||
| Q2 25 | 62.6% | 95.6% | ||
| Q1 25 | 62.0% | 91.7% | ||
| Q4 24 | 61.3% | 89.9% | ||
| Q3 24 | 65.5% | 85.5% | ||
| Q2 24 | 63.6% | 92.4% |
营业利润率AATRIGL
| Q1 26 | 23.4% | — | ||
| Q4 25 | 21.1% | 33.2% | ||
| Q3 25 | 22.6% | 40.9% | ||
| Q2 25 | 24.1% | 60.1% | ||
| Q1 25 | 66.3% | 23.9% | ||
| Q4 24 | 26.5% | 28.9% | ||
| Q3 24 | 30.8% | 25.4% | ||
| Q2 24 | 27.8% | 1.2% |
净利率AATRIGL
| Q1 26 | 6.1% | — | ||
| Q4 25 | — | 384.0% | ||
| Q3 25 | 4.1% | 40.2% | ||
| Q2 25 | 5.1% | 58.6% | ||
| Q1 25 | 39.2% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 13.6% | 22.5% | ||
| Q2 24 | 10.7% | -2.8% |
每股收益（稀释后）AATRIGL
| Q1 26 | $0.08 | — | ||
| Q4 25 | $0.06 | $14.11 | ||
| Q3 25 | $0.07 | $1.46 | ||
| Q2 25 | $0.09 | $3.28 | ||
| Q1 25 | $0.70 | $0.63 | ||
| Q4 24 | $0.14 | $0.82 | ||
| Q3 24 | $0.28 | $0.70 | ||
| Q2 24 | $0.20 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $118.3M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.1B | $391.5M |
| 总资产 | $2.9B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AATRIGL
| Q1 26 | $118.3M | — | ||
| Q4 25 | $129.4M | $155.0M | ||
| Q3 25 | $138.7M | $137.1M | ||
| Q2 25 | $143.7M | $108.4M | ||
| Q1 25 | $143.9M | $77.1M | ||
| Q4 24 | $425.7M | $77.3M | ||
| Q3 24 | $533.0M | $61.1M | ||
| Q2 24 | $114.9M | $49.1M |
总债务AATRIGL
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $2.0B | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益AATRIGL
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.2B | $391.5M | ||
| Q3 25 | $1.2B | $117.6M | ||
| Q2 25 | $1.2B | $81.9M | ||
| Q1 25 | $1.2B | $18.6M | ||
| Q4 24 | $1.2B | $3.3M | ||
| Q3 24 | $1.2B | $-14.6M | ||
| Q2 24 | $1.2B | $-29.9M |
总资产AATRIGL
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $513.6M | ||
| Q3 25 | $2.9B | $242.5M | ||
| Q2 25 | $3.0B | $206.7M | ||
| Q1 25 | $3.0B | $176.0M | ||
| Q4 24 | $3.3B | $164.0M | ||
| Q3 24 | $3.4B | $139.4M | ||
| Q2 24 | $3.0B | $128.4M |
负债/权益比AATRIGL
| Q1 26 | — | — | ||
| Q4 25 | 1.48× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 1.72× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 14.5% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AATRIGL
| Q1 26 | — | — | ||
| Q4 25 | $167.1M | $22.0M | ||
| Q3 25 | $40.5M | $24.0M | ||
| Q2 25 | $49.2M | $30.5M | ||
| Q1 25 | $36.9M | $-893.0K | ||
| Q4 24 | $207.1M | $14.5M | ||
| Q3 24 | $52.4M | $21.7M | ||
| Q2 24 | $59.3M | $302.0K |
自由现金流AATRIGL
| Q1 26 | — | — | ||
| Q4 25 | $94.9M | — | ||
| Q3 25 | $23.1M | — | ||
| Q2 25 | $28.4M | — | ||
| Q1 25 | $20.4M | — | ||
| Q4 24 | $136.9M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $43.6M | — |
自由现金流率AATRIGL
| Q1 26 | — | — | ||
| Q4 25 | 86.2% | — | ||
| Q3 25 | 21.1% | — | ||
| Q2 25 | 26.3% | — | ||
| Q1 25 | 18.8% | — | ||
| Q4 24 | 120.7% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 39.3% | — |
资本支出强度AATRIGL
| Q1 26 | 14.5% | — | ||
| Q4 25 | 65.6% | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 15.1% | — | ||
| Q4 24 | 61.9% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 14.1% | — |
现金转化率AATRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | 8.98× | 0.86× | ||
| Q2 25 | 9.01× | 0.51× | ||
| Q1 25 | 0.87× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 3.15× | 1.75× | ||
| Q2 24 | 4.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AAT
| Rental income | $104.4M | 94% |
| Other | $6.2M | 6% |
RIGL
暂无分部数据
